Comparing the Effectiveness of Two Approaches to Preventing Severe Hypoglycemia in Patients With Type 2 Diabetes (PHT2) (PHT2)
Comparing the Effectiveness of Two Approaches to Preventing Severe Hypoglycemia
Sponsor: Kaiser Permanente
Listed as NCT04863872, this NA trial focuses on Severe Hypoglycemia and remains completed. Sponsored by Kaiser Permanente, it has been updated 6 times since 2022, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
6 versions recorded-
Jun 2025 — Present [monthly]
Completed NA
-
Sep 2024 — Jun 2025 [monthly]
Completed NA
Status: Active Not Recruiting → Completed · Phase: PHASE3 → NA
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting PHASE3
-
Dec 2023 — Jul 2024 [monthly]
Active Not Recruiting PHASE3
Status: Unknown Status → Active Not Recruiting
-
Jun 2023 — Dec 2023 [monthly]
Unknown Status PHASE3
Status: Not Yet Recruiting → Unknown Status
▶ Show 1 earlier version
-
May 2021 — Jun 2023 [monthly]
Not Yet Recruiting PHASE3
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Kaiser Permanente
- Patient-Centered Outcomes Research Institute
For direct contact, visit the study record on ClinicalTrials.gov .